ZYTIGA

Tablet, 250mg
RxActive license

Active substance (INN)

abiraterone

Pharmaceutical form

Pharmaceutical formTablet
Strength250mg
PackagingUkupno 120 tableta u boci plastičnoj u kartonskoj kutiji
ManufacturerJanssen Cilag S.p.A., Italy
Therapeutic groupAntineoplastic and immunomodulating agents (L02BX03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateDecember 16, 2024

Analogs in Montenegro

8

Other medicines with the same active substance

ABESINERx
Film-coated tablet, 250mgPharmadox Healthcare Ltd.
Abirateron EGRestricted
Film-coated tablet, 500mgStada Arzneimittel AG
ABIRATERON TEVARx
Film-coated tablet, 500mgBalkanpharma Dupnitsa AD
ENAGALRx
Film-coated tablet, 500mgRemedica Ltd.
ENAGALRx
Film-coated tablet, 250mgRemedica Ltd.
JONOSOLRestricted
Film-coated tablet, 250mgStada Arzneimittel AG
REMABIRATRx
Film-coated tablet, 250mgRemedica Ltd.
REMABIRATRx
Film-coated tablet, 500mgRemedica Ltd.
Source: CInMED register